...Neurodegenerative disease start-up CuraSen Therapeutics Inc. (San Mateo, Calif.) hired Gabriel Vargas as its first CMO. Vargas led...

...After debuting with a $54.5 million series A round, CuraSen Therapeutics Inc. hopes to generate clinical proof-of-concept data...
...& Co. Inc. (NYSE:MRK) acquired Afferent in 2016 for $500 million up front. Chris Lieu, Staff Writer CuraSen Therapeutics Inc. Parkinson's...

...Neurodegenerative disease company CuraSen Therapeutics Inc. (San Mateo, Calif.) raised $54.5 million in a series A round on...
...bring a program into the clinic by the end of 2019. CuraSen Therapeutics Inc., San Mateo, Calif. Chris Lieu CuraSen Therapeutics Inc....

...Neurodegenerative disease company CuraSen Therapeutics Inc. (San Mateo, Calif.) raised $54.5 million in a series A round led...
...Glaub. CuraSen hopes to bring a program into the clinic by the end of 2019. Chris Lieu CuraSen Therapeutics Inc. Stanford...